Skip to main content

Find Clinical Trials

Home
Conditions
Invasive Breast Carcinoma

Clinical trial condition

Invasive Breast Carcinoma

Explore clinical trials studying Invasive Breast Carcinoma. Study availability and eligibility vary by location and protocol.

91 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Invasive Breast Carcinoma trial results

Completed

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

NCT02282345

Conditions: Breast Adenocarcinoma, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

NCT03518242

Conditions: Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +9 more
Locations: New Mulago Hospital Kampala, Uganda

Uganda Cancer Institute Kampala, Uganda

View Trial Details

Completed

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

NCT01849250

Conditions: Adenocarcinoma, Benign Breast Neoplasm, Breast Carcinoma In Situ, +24 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Columbia University/Herbert Irving Cancer Center New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Home-Based Walking Program and rTMS in Helping Breast Cancer Survivors Get More Physical Activity

NCT03789877

Conditions: Cancer Survivor, Invasive Breast Carcinoma
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Broccoli Sprout Extract in Treating Patients With Breast Cancer

NCT01753908

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +25 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Metastatic Triple-Negative Breast Cancer

NCT01964924

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +11 more
Locations: MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

Moffitt Cancer Center Tampa, Florida, United States

Roswell Park Cancer Institute Buffalo, New York, United States

UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States

View Trial Details

Completed

Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer

NCT02370277

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +17 more
Locations: USC Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab Only

NCT01434303

Conditions: Breast Diseases, Breast Neoplasms, HER2/Neu Positive, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT01344031

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Positive, +7 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer

NCT00429182

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details